SCHEMBL21687980

SCHEMBL21687980

N#Cc1cccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)c1-c1ccccc1-n1c2ccccc2c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
HIF1A Q16665 1/20 0.35
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPT P10636 2/20 0.33
STAT3 P40763 1/20 0.33
IMPDH2 P12268 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ACP1 P24666 1/20 0.31
HTT P42858 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
CLK4 Q9HAZ1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687764 0.93 SMN1; SMN2 (0.41) SMN1; SMN2HIF1AALDH1A1MEN1TSHR
SCHEMBL21688020 0.92 HRH1 (0.35) SMN1; SMN2HIF1A
SCHEMBL21687982 0.90 SMN1; SMN2 (0.35) SMN1; SMN2HIF1AALDH1A1MEN1TSHR
SCHEMBL21687786 0.90 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AALDH1A1MEN1TSHR
SCHEMBL21687927 0.88 SMN1; SMN2 (0.34) SMN1; SMN2HIF1AALDH1A1MEN1TSHR
SCHEMBL21688009 0.88 HRH1 (0.35) SMN1; SMN2HIF1AALDH1A1KDM4E
SCHEMBL21688186 0.88 MAPT (0.32) SMN1; SMN2HIF1AALDH1A1MEN1TSHR
SCHEMBL21687789 0.88 HRH1 (0.31) SMN1; SMN2HIF1AALDH1A1MEN1TSHR
SCHEMBL21687769 0.87 SMN1; SMN2 (0.38) SMN1; SMN2HIF1AALDH1A1IMPDH2KDM4E
SCHEMBL21687652 0.86 SMN1; SMN2 (0.34) SMN1; SMN2HIF1AALDH1A1MEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885HIF1A 622/4885ALDH1A1 616/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885HIF1A 622/4885ALDH1A1 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.